Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Cancer News Genetics May Predict Bladder Cancer Immunotherapy Response Science Daily

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Cancer News Genetics May Predict Bladder Cancer Immunotherapy Response Science Daily is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Cancer News Genetics May Predict Bladder Cancer Immunotherapy Response Science Daily | RobinsPost News & Noticias

Are cancer surgeries removing the body’s secret weapon against cancer?


Scientists have found that preserving lymph nodes during cancer surgery could dramatically improve how patients respond to immunotherapy. The research shows that lymph nodes are essential for training ... Read More

The next cancer-fighting mRNA vaccine may already be here


Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days before starting their treatment lived longer. Read More

'Remarkable' Survival Outcomes in Cisplatin-Ineligible Bladder Cancer


The perioperative enfortumab vedotin plus pembrolizumab (EV-P) substantially increased the frequency of adverse events (AEs), including severe AEs, but considered manageable, reported Christof ... Read More

New data sheds light on immunotherapy failure, bringing hope to patients with cancer


A new study by researchers from the University of Birmingham and the University of Turku, Finland has revealed an important clue as to why immunotherapy fails in many patients with cancer. For the ... Read More

FDA Nod for J&J’s Drug/Device Treatment Gives Bladder Cancer Patients Another Option


Bladder cancer patients who have an early but aggressive form of the disease that’s unresponsive to the standard of care now have a new treatment option, an implanted Johnson & Johnson drug/device ... Read More

Scientists find immune drug that could halt skin cancer’s deadly spread


Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients with Merkel cell carcinoma after surgery. Though recurrence rates overall ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus